BSE Live
Jan 01, 16:01Prev. Close
73.25
Open Price
72.11
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 01, 15:41Prev. Close
73.32
Open Price
71.50
Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Bal Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 167.25 | 218.69 | 206.32 | 227.36 | 198.33 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 6.07 | 4.17 | |
| Revenue From Operations [Net] | 167.25 | 218.69 | 206.32 | 221.29 | 194.16 | |
| Total Operating Revenues | 170.67 | 223.08 | 209.85 | 225.94 | 197.66 | |
| Other Income | 3.62 | 2.75 | 1.67 | 3.39 | 1.50 | |
| Total Revenue | 174.29 | 225.83 | 211.52 | 229.33 | 199.15 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 72.19 | 113.64 | 104.92 | 115.47 | 97.68 | |
| Purchase Of Stock-In Trade | 8.70 | 7.70 | 6.94 | 6.68 | 7.39 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 3.32 | -4.41 | -11.24 | -6.13 | -0.38 | |
| Employee Benefit Expenses | 48.77 | 48.45 | 49.61 | 41.35 | 35.67 | |
| Finance Costs | 12.42 | 12.53 | 9.11 | 8.46 | 6.48 | |
| Depreciation And Amortisation Expenses | 7.03 | 6.12 | 6.73 | 6.46 | 6.97 | |
| Other Expenses | 30.93 | 37.39 | 37.00 | 48.45 | 40.16 | |
| Total Expenses | 183.36 | 221.41 | 203.07 | 220.74 | 193.97 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -9.08 | 4.41 | 8.45 | 8.59 | 5.18 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -9.08 | 4.41 | 8.45 | 8.59 | 5.18 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 1.03 | 2.55 | 2.18 | 1.24 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | -0.70 | |
| Deferred Tax | -0.03 | -3.30 | -0.04 | 0.95 | -0.33 | |
| Tax For Earlier Years | -0.15 | -0.08 | 0.00 | 0.15 | 0.77 | |
| Total Tax Expenses | -0.17 | -2.35 | 2.52 | 3.28 | 2.38 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -8.90 | 6.76 | 5.94 | 5.31 | 2.81 | |
| Profit/Loss From Continuing Operations | -8.90 | 6.76 | 5.94 | 5.31 | 2.81 | |
| Profit/Loss For The Period | -8.90 | 6.76 | 5.94 | 5.31 | 2.81 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -6.28 | 4.77 | 4.19 | 3.50 | 2.18 | |
| Diluted EPS (Rs.) | -6.28 | 4.77 | 4.19 | 3.50 | 2.18 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 24.54 | 33.20 | 38.16 | 57.87 | 47.01 | |
| Indigenous Raw Materials | 38.78 | 67.20 | 54.05 | 45.28 | 39.96 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.29 | 0.85 | 1.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.42 | 1.71 | 0.00 | 1.42 | 1.42 | |
| Tax On Dividend | 0.29 | 0.00 | 0.00 | 0.29 | 0.29 | |
| Equity Dividend Rate (%) | 0.00 | 10.00 | 10.00 | 10.00 | 10.00 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y